Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC
- Resource Type
- Article
- Authors
- Zhou, Nanruoyi; Velez, Maria A; Bachrach, Benjamin; Gukasyan, Jaklin; Fares, Charlene M.; Cummings, Amy L.; Lind-Lebuffe, Jackson P.; Akingbemi, Wisdom O.; Li, Debory Y.; Brodrick, Paige M.; Yessuf, Nawal M.; Rettinger, Sarah; Grogan, Tristan; Rochigneux, Philippe; Goldman, Jonathan W.; Garon, Edward B.; Lisberg, Aaron
- Source
- In Lung Cancer November 2021 161:34-41
- Subject
- Language
- ISSN
- 0169-5002